{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:44:29Z","timestamp":1781196269777,"version":"3.54.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> An acute respiratory distress syndrome (ARDS) is caused by the increased amounts of pro-inflammatory cytokines and neutrophil-mediated tissue injury. To date, there is no effective treatment for the ARDS available, while the need for one is growing due to the most severe complications of the current coronavirus disease-2019 (COVID-19) pandemic. The human astrocytes (AstroRx) have shown immunomodulatory properties in the central nervous system (CNS). This study aimed to evaluate the capacity of astrocytes to decrease lung inflammation and to be applied as a treatment therapy in ARDS.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> First, we assessed the ability of clinical-grade AstroRx to suppress T-cell proliferation in a mixed lymphocyte reaction test. Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). We determined the degree of lung injury by using a severity scoring scale of 0\u20132, based on the American Thoracic Society. The scoring measured the presence of neutrophils, fibrin deposits, and the thickening of alveolar walls. The state of inflammation was further assessed by quantifying the immune-cell infiltration to the bronchoalveolar lavage fluid (BALF) and by the presence of proinflammatory cytokines and chemokines in the BALF and serum.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We detected that AstroRx cells were capable to suppress T-cell proliferation <jats:italic>in vitro<\/jats:italic> after exposure to the mitogen concanavalin A (ConA). <jats:italic>In vivo<\/jats:italic>, AstroRx cells were able to lower the degree of lung injury in LPS-treated animals compared with the sham injected animals (<jats:italic>P<\/jats:italic> = 0.039). In this study, 30% of AstroRx treated mice showed no lung lesions (responder mice), these mice presented a steady number of eosinophils, T cells, and neutrophils comparable with the level of na\u00efve control mice. The inflammatory cytokines and chemokines, such as TNF\u03b1, IL1b, IL-6, and CXCL1, were also kept in check in responder AstroRx-treated mice and were not upregulated as in the sham-injected mice (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). As a result, the LPS-treated ARDS mice had a higher survival rate when they were treated with AstroRx.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Our results demonstrate that the immunosuppressive activity of AstroRx cells support the application of AstroRx cells as a cell therapy treatment for ARDS. The immunoregulatory activity may also be a part of the mechanism of action of AstroRx reported in the amyotrophic lateral sclerosis (ALS) neurodegenerative disease.<\/jats:p>","DOI":"10.3389\/fmed.2021.740071","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:43:19Z","timestamp":1635486199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19"],"prefix":"10.3389","volume":"8","author":[{"given":"Michal","family":"Izrael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kfir","family":"Molakandov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Revel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalom Guy","family":"Slutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehila","family":"Sonnenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Miriam","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Revel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.gendis.2020.06.009","article-title":"Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome","volume":"7","author":"Lin","year":"2020","journal-title":"Genes Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","article-title":"Review of the clinical characteristics of Coronavirus disease 2019 (COVID-19)","volume":"35","author":"Jiang","year":"2020","journal-title":"J Gen Intern Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ajem.2020.06.028","article-title":"Cardiac injury, ARDS and COVID-19 meta-analysis validity - Correspondence in response to Santoso et al","volume":"42","author":"Carver","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/cid\/ciaa242","article-title":"Analysis of epidemiological and clinical features in older patients with Coronavirus disease 2019 (COVID-19) outside Wuhan","volume":"71","author":"Lian","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1590\/S0102-35862003000400013","article-title":"Lung parenchyma remodeling in acute respiratory distress syndrome","volume":"75","author":"Rocco","year":"2009","journal-title":"Minerva Anestesiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2213-2600(13)70053-5","article-title":"Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies","volume":"1","author":"Thille","year":"2013","journal-title":"Lancet Respir Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00134-014-3613-0","article-title":"Understanding ARDS-associated fibroproliferation","volume":"41","author":"Meduri","year":"2015","journal-title":"Intensive Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"118167","DOI":"10.1016\/j.lfs.2020.118167","article-title":"The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"258","author":"Akbari","year":"2020","journal-title":"Life Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fphar.2020.00796","article-title":"Reducing the fatality rate of COVID-19 by applying clinical insights from immuno-oncology and lung transplantation","volume":"11","author":"Uckun","year":"2020","journal-title":"Front Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/1073858420941476","article-title":"COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation","volume":"26","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1753466620933508","DOI":"10.1177\/1753466620933508","article-title":"Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications","volume":"14","author":"Pelaia","year":"2020","journal-title":"Ther Adv Respir Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(20)30553-5","article-title":"Health security capacities in the context of COVID-19 outbreak: an analysis of international health regulations annual report data from 182 countries","volume":"395","author":"Kandel","year":"2020","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00134-020-06251-8","article-title":"Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS","volume":"46","author":"Ferrando","year":"2020","journal-title":"Intensive Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10565-019-09493-5","article-title":"Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome","volume":"36","author":"Lopes-Pacheco","year":"2020","journal-title":"Cell Biol Toxicol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/sctm.20-0186","article-title":"Current status of mesenchymal stem cell therapy for immune\/inflammatory lung disorders: gleaning insights for possible use in COVID-19","volume":"9","author":"Yen","year":"2020","journal-title":"Stem Cells Transl Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.2174\/1381612825666191204092456","article-title":"Alveolar type 2 epithelial cells as potential therapeutics for acute lung injury\/acute respiratory distress syndrome","volume":"25","author":"Zhang","year":"2019","journal-title":"Curr Pharm Des."},{"key":"B20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13054-019-2339-3","article-title":"Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury","volume":"23","author":"Zhou","year":"2019","journal-title":"Crit Care."},{"key":"B21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-cellbio-100913-013053","article-title":"Astrocyte regulation of synaptic behavior","volume":"30","author":"Allen","year":"2014","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2017.09.056","article-title":"Cell biology of astrocyte-synapse interactions","volume":"96","author":"Allen","year":"2017","journal-title":"Neuron."},{"key":"B23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fnins.2020.00824","article-title":"Rising stars: astrocytes as a therapeutic target for ALS disease","volume":"14","author":"Izrael","year":"2020","journal-title":"Front Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/glia.23471","article-title":"Directional coupling of oligodendrocyte connexin-47 and astrocyte connexin-43 gap junctions","volume":"66","author":"Fasciani","year":"2018","journal-title":"Glia."},{"key":"B25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity."},{"key":"B27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.it.2007.01.005","article-title":"Astrocytes are active players in cerebral innate immunity","volume":"28","author":"Farina","year":"2007","journal-title":"Trends Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00401-015-1513-1","article-title":"Astrocytes: a central element in neurological diseases","volume":"131","author":"Pekny","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"a020420","DOI":"10.1101\/cshperspect.a020420","article-title":"Astrogliosis","volume":"7","author":"Sofroniew","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1073858413504466","article-title":"Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators","volume":"20","author":"Sofroniew","year":"2014","journal-title":"Neuroscientist."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/NEN.0b013e31818f9ca8","article-title":"Perivascular spaces and the two steps to neuroinflammation","volume":"67","author":"Owens","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J Clin Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/WCO.0000000000000599","article-title":"Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis","volume":"31","author":"Thonhoff","year":"2018","journal-title":"Curr Opin Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13287-018-0890-5","article-title":"Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1(G93A) and NSG animal models","volume":"9","author":"Izrael","year":"2018","journal-title":"Stem Cell Res Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ana.21033","article-title":"Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression","volume":"61","author":"Einstein","year":"2007","journal-title":"Ann Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","article-title":"Animal models of acute lung injury","volume":"295","author":"Matute-Bello","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","article-title":"Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis","volume":"16","author":"Kuhle","year":"2009","journal-title":"Eur J Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-7-76","article-title":"IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients","volume":"7","author":"Fiala","year":"2010","journal-title":"J Neuroinflamm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1212\/01.wnl.0000188907.97339.76","article-title":"Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?","volume":"65","author":"Moreau","year":"2005","journal-title":"Neurology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.09.017","article-title":"Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)","volume":"206","author":"Zhang","year":"2009","journal-title":"J Neuroimmunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13287-019-1518-0","article-title":"Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome","volume":"10","author":"Han","year":"2019","journal-title":"Stem Cell Res Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","journal-title":"Stem Cells Dev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neulet.2014.04.046","article-title":"Anti-inflammatory cytokine interleukin-10 increases resistance to brain ischemia through modulation of ischemia-induced intracellular Ca(2)(+) response","volume":"571","author":"Tukhovskaya","year":"2014","journal-title":"Neurosci Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1523\/JNEUROSCI.15-08-05535.1995","article-title":"Adrenergic calcium signaling in astrocyte networks within the hippocampal slice","volume":"15","author":"Duffy","year":"1995","journal-title":"J Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.neuroscience.2009.01.005","article-title":"In inflammatory reactive astrocytes co-cultured with brain endothelial cells nicotine-evoked Ca(2+) transients are attenuated due to interleukin-1beta release and rearrangement of actin filaments","volume":"159","author":"Delbro","year":"2009","journal-title":"Neuroscience."},{"key":"B49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1073\/pnas.1015217108","article-title":"Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ signaling events elicited by cerebral edema","volume":"108","author":"Thrane","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B50","doi-asserted-by":"publisher","first-page":"14489","DOI":"10.1523\/JNEUROSCI.1256-12.2012","article-title":"Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors","volume":"32","author":"Hamby","year":"2012","journal-title":"J Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","article-title":"Selective induction of astrocytic gliosis generates deficits in neuronal inhibition","volume":"13","author":"Ortinski","year":"2010","journal-title":"Nat Neurosci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.740071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:43:23Z","timestamp":1635486203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.740071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":51,"alternative-id":["10.3389\/fmed.2021.740071"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.740071","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"article-number":"740071"}}